Executives On The Move: Development Hires At BiomX And CytomX, Revance Chooses a CEO
• By Regina Paleski
Two new chief development officers: former Teva Pharma exec moves to microbiome-based therapeutics firm BiomX; and BioGene CMO makes a change to oncology biopharma CytomX. At Revance Therapeutics, a developer of therapeutic neuromodulators, a CEO is chosen.
Recent moves in the industry include C-suite changes at Abvance Therapeutics, plus Galapagos gets new chief financial officer from Horizon Therapeutics.
Recent moves in the industry include changes at the top at iOnctura
and Orca Bio, plus Sutro Biopharma, Tenpoint Therapeutics and Helix BioPharma get new CFOs.